Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector

Human Gene Therapy

Volumn 15, Issue 9, 2004, Pages 832-841

  Sirninger, Jeffrey ^a   Muller, Christian ^a   Braag, Sofia ^a   Tang, Qiushi ^a   Yue, Hungwen ^b   Detrisac, Carol ^d   Ferkol, Thomas ^c   Guggino, William B ^b   Flotte, Terence R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d Charles River Pathology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CELL SURFACE RECEPTOR; CHLORINE 36; PARVOVIRUS VECTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 2; ADENO ASSOCIATED VIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOMEGALOVIRUS; ENHANCER REGION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG DISEASE; MOUSE; NONHUMAN; PATCH CLAMP; PNEUMONIA; PROMOTER REGION; PSEUDOMONAS; RESPIRATORY TRACT INFLAMMATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROUS SARCOMA ONCOVIRUS; VIRUS CAPSID; VIRUS RECOMBINANT; WEIGHT REDUCTION;

ACTINS; ANIMALS; CHLORIDE CHANNELS; CLONING, MOLECULAR; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DEPENDOVIRUS; DNA, RECOMBINANT; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; LUCIFERASES; MICE; PNEUMONIA; PROMOTER REGIONS (GENETICS); PSEUDOMONAS AERUGINOSA; WEIGHT LOSS;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ADENO-ASSOCIATED VIRUS 5; ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; ONCOVIRINAE; PARVOVIRUS; PSEUDOMONAS; ROUS SARCOMA VIRUS;

EID: 4544377145     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/1043034041839262     Document Type: Article

References (28)

1. AFIONE, S.A., CONRAD, C.K., KEARNS, W.G., CHUNDURU, S., ADAMS, R., REYNOLDS, T.C., GUGGINO, W.B., CUTTING, G.R., CARTER, B.J., and FLOTTE, T.R. (1996). In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70, 3235-3241.
2. AFIONE, S.A., WANG, J., WALSH, S., GUGGINO, W.B., and FLOTTE, T.R. (1999). Delayed expression of adeno-associated virus vector DNA. Intervirology 42, 213-220.
3. AITKEN, M.L., MOSS, R.B., WALTZ, D.A., DOVEY, M.E., TONELLI, M.R., MCNAMARA, S.C., GIBSON, R.L., RAMSEY, B.W., CARTER, B.J., and REYNOLDS, T.C. (2001). A phase 1 study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum. Gene Ther. 12, 1907-1916.
4. CARROLL, T.P., MORALES, M.M., FULMER, S.B., ALLEN, S.S., FLOTTE, T.R., CUTTING, G.R., and GUGGINO, W.B. (1995). Alternate translation initiation codons can create functional forms of cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 270, 11941-11946.
5. CONRAD, C.K., ALLEN, S.S., AFIONE, S.A., REYNOLDS, T.C., BECK, S.E., FEE-MAKI, M., BARRAZZA-ORTIZ, X., ADAMS, R., ASKIN, F.B., CARTER, B.J., GUGGINO, W.B., and FLOTTE, T.R. (1996). Safety of single-dose administration of an adeno-associated virus (AAV)- CFTR vector in the primate lung. Gene Ther. 3, 658-668.
6. DUAN, D., YUE, Y., YAN, Z., MCCRAY, P.B., Jr., and ENGELHARDT, J.F. (1998). Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum. Gene Ther. 9, 2761-2776.
7. DUAN, D., YUE, Y., YAN, Z., YANG, J., and ENGELHARDT, J.F. (2000). Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J. Clin. Invest. 105, 1573-1587.
8. EGAN, M., FLOTTE, T., AFIONE, S., SOLOW, R., ZEITLIN, P.L., CARTER, B.J., and GUGGINO, W.B. (1992). Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR [see comments]. Nature 358, 581-584.
9. FLOTTE, T.R., SOLOW, R., OWENS, R.A., AFIONE, S., ZEITLIN, P.L., and CARTER, B.J. (1992). Gene expression from adeno-associated virus vectors in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 7, 349-356.
10. FLOTTE, T.R., AFIONE, S.A., CONRAD, C., MCGRATH, S.A., SOLOW, R., OKA, H., ZEITLIN, P.L., GUGGINO, W.B., and CARTER, B.J. (1993a). Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. U.S.A. 90, 10613-10617.
11. FLOTTE, T.R., AFIONE, S.A., SOLOW, R., DRUMM, M.L., MARKAKIS, D., GUGGINO, W.B., ZEITLIN, P.L., and CARTER, B.J. (1993b). Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268, 3781-3790.
12. FLOTTE, T., CARTER, B., CONRAD, C., GUGGINO, W., REYNOLDS, T., ROSENSTEIN, B., TAYLOR, G., WALDEN, S., and WETZEL, R. (1996). A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum. Gene Ther. 7, 1145-1159.
13. FLOTTE, T., AGARWAL, A., WANG, J., SONG, S., FENJVES, E.S., INVERARDI, L., CHESNUT, K., AFIONE, S., LOILER, S., WASSERFALL, C., KAPTURCZAK, M., ELLIS, T., NICK, H., and ATKINSON, M. (2001). Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors. Diabetes 50, 515-520.
14. FLOTTE, T.R., ZEITLIN, P.L., REYNOLDS, T.C., HEALD, A.E., PEDERSEN, P., BECK, S., CONRAD, C.K., BRASS-ERNST, L., HUMPHRIES, M., SULLIVAN, K., WETZEL, R., TAYLOR, G., CARTER, B.J., and GUGGINO, W.B. (2003). Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study. Hum. Gene Ther. 14, 1079-1088.
15. HALBERT, C.L., STANDAERT, T.A., AITKEN, M.L., ALEXANDER, I.E., RUSSELL, D.W., and MILLER, A.D. (1997). Transduction by adeno-associated virus vectors in the rabbit airway: Efficiency, persistence, and readministration. J. Virol. 71, 5932-5941.
16. HALBERT, C.L., ALLEN, J.M., and MILLER, A.D. (2001). Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J. Virol. 75, 6615-6624.
17. HEECKEREN, A., WALENGA, R., KONSTAN, M.W., BONFIELD, T., DAVIS, P.B., and FERKOL, T. (1997). Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J. Clin. Invest. 100, 2810-2815.
18. KEARNS, W.G., AFIONE, S.A., FULMER, S.B., PANG, M.C., ERIKSON, D., EGAN, M., LANDRUM, M.J., FLOTTE, T.R., and CUTTING, G.R. (1996). Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3, 748-755.
19. LOILER, S.A., CONLON, T.J., SONG, S., TANG, Q., WARRINGTON, K.H., AGARWAL, A., KAPTURCZAK, M., LI, C., RICORDI, C., ATKINSON, M.A., MUZYCZKA, N., and FLOTTE, T.R. (2003). Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Ther. 10, 1551-1558.
20. SANLIOGLU, S., DUAN, D., and ENGELHARDT, J.F. (1999). Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction. Hum. Gene Ther. 10, 591-602.
21. TRAPNELL, B.C., CHU, C.S., PAAKKO, P.K., BANKS, T.C., YOSHIMURA, K., FERRANS, V.J., CHERNICK, M.S., and CRYSTAL, R.G. (1991). Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc. Natl. Acad. Sci. U.S.A. 88, 6565-6569.
22. WAGNER, J.A., MORAN, M.L., MESSNER, A.H., DAIFUKU, R., CONRAD, C.K., REYNOLDS, T., GUGGINO, W.B., MOSS, R.B., CARTER, B.J., WINE, J.J., FLOTTE, T.R., and GARDNER, P. (1998a). A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis. Hum. Gene Ther. 9, 889-909.
23. WAGNER, J.A., REYNOLDS, T., MORAN, M.L., MOSS, R.B., WINE, J.J., FLOTTE, T.R., and GARDNER, P. (1998b). Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus [letter]. Lancet 351, 1702-1703.
24. WAGNER, J.A., MESSNER, A.H., MORAN, M.L., DAIFUKU, R., KOUYAMA, K., DESCH, J.K., MANLY, S., NORBASH, A.M., CONRAD, C.K., FRIBORG, S., REYNOLDS, T., GUGGINO, W.B., MOSS, R.B., CARTER, B.J., WINE, J.J., FLOTTE, T.R., and GARDNER, P. (1999). Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane conductance regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Laryngoscope 109, 266-274.
25. WAGNER, J.A., NEPOMUCENO, I.B., MESSNER, A.H., MORAN, M.L., BATSON, E.P., DIMICELI, S., BROWN, B.W., DESCH, J.K., NORBASH, A.M., CONRAD, C.K., GUGGINO, W.B., FLOTTE, T.R., WINE, J.J., CARTER, B.J., REYNOLDS, T.C., MOSS, R.B., and GARDNER, P. (2002). A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum. Gene Ther. 13, 1349-1359.
26. YAN, Z., ZAK, R., LUXTON, G.W., RITCHIE, T.C., BANTELSCHAAL, U., and ENGELHARDT, J.F. (2002). Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J. Virol. 76, 2043-2053.
27. ZABNER, J., SEILER, M., WALTERS, R., KOTIN, R.M., FULGERAS, W., DAVIDSON, B.L., and CHIORINI, J.A. (2000). Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74, 3852-3858.
28. ZOLOTUKHIN, S., POTTER, M., ZOLOTUKHIN, I., SAKAI, Y., LOILER, S., FRAITES, T.J., Jr., CHIODO, V.A., PHILLIPSBERG, T., MUZYCZKA, N., HAUSWIRTH, W.W., FLOTTE, T.R., BYRNE, B.J., and SNYDER, R.O. (2002). Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28, 158-167.